Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis

Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summarize data on PZA resistance in clinical isolates from South Africa. PZA DST should be performed when considering its inclusion in treatment of patients with rifampicin-resistant TB or MDR-TB.

Na minha lista:
Detalhes bibliográficos
Publicado no:Tuberculosis (Edinb)
Main Authors: Whitfield, M.G., Streicher, E.M., Dolby, T., Simpson, J.A, Sampson, S.L., Van Helden, P.D., Van Rie, A., Warren, R.M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963978/
https://ncbi.nlm.nih.gov/pubmed/27450014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2016.05.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados